Evo2 Proposes Sequences
The Stanford speaker says Evo2 can act like a chat GPT for the genome, proposing new variations that improve downstream outcomes. Protein design literature supplies the industrial frame: Generate:Biomedicines uses machine learning to design and optimize proteins for therapeutics. The jump from a DNA proposal to a working de novo enzyme remains a test, not a guarantee.






